Kyle Faget Discusses Regulating Software as a Medical Device on MedTech Connect Podcast
January 6, 2023
Medtech Insight
Foley & Lardner LLP Partner Kyle Faget is interviewed in the first episode of MedTech Connect, a new digital health podcast series by Medtech Insight, about the complexities behind regulating software as a medical device (SaMD).
In the episode, “How Do We Regulate Software as a Medical Device?” Faget offers valuable insight on the regulatory landscape of SaMD, and provides clarity for businesses that might be unsure if their software is even regulated by the U.S. Food and Drug Administration, let alone understand how to go about the clearance process.
Listen to the episode on Apple Podcasts, SoundCloud, and Spotify.
(Subscription required)
People
Related News
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."